Early Stage Lung Cancer
Showing 26 - 50 of >10,000
NSCLC Trial in Shanghai (Carbon ion beam radiotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Carbon ion beam radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
Nov 10, 2022
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
Completed
- Small Cell Lung Cancer
- atezolizumab
-
Chalon-sur-Saône, France
- +1 more
Jan 5, 2023
NSCLC Trial in Hamilton (indocyanine green)
Recruiting
- Non-small Cell Lung Cancer
- indocyanine green
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare Hamilton
May 11, 2021
Lung Cancer Trial in Indianapolis (Stereotactic Ablative Body Radiation (SABR))
Terminated
- Lung Cancer
- Stereotactic Ablative Body Radiation (SABR)
-
Indianapolis, Indiana
- +2 more
Jul 22, 2022
NSCLC Trial in Philadelphia (device, drug, other)
Not yet recruiting
- NSCLC
- Aliya Pulsed Electric Fields (PEF) ablation
- +3 more
-
Philadelphia, PennsylvaniaTemple University
Oct 24, 2022
Lung Cancer, Nonsmall Cell, Stage IIIA, Lung Cancer Non-Small Cell Stage IIIB, Lung Cancer Non-Small Cell Stage III Trial in
Not yet recruiting
- Lung Cancer, Nonsmall Cell, Stage IIIA
- +4 more
- E-health ecosystem of stepped psychosocial care
- Usual psychosocial care
-
L'Hospitalet De Llobregat, Catalunya, SpainInstitut Català d'Oncologia
Aug 9, 2022
NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- AVENIO ctDNA Surveillance Kit
- Durvalumab
-
Stanford, CaliforniaStanford University
Mar 25, 2022
NSCLC Trial (Cardiac biomarkers, Echocardiography,Cardiac magnetic resonance imaging)
Not yet recruiting
- Non-small Cell Lung Cancer
- Cardiac biomarkers, Echocardiography,Cardiac magnetic resonance imaging
- (no location specified)
Feb 19, 2022
NSCLC Metastatic Trial in Shanghai (Oba01)
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
-
Shanghai, ChinaDepartment of Oncology, Shanghai Lung Cancer Center, Shanghai Ch
Oct 9, 2023
Sarcopenia and Nutritional Status in Early-stage Non-small Cell
Not yet recruiting
- Sarcopenia
- +2 more
- Inbody 570
- +2 more
-
Shanghai, Shanghai, ChinaHuadong hospital, Fudan University
Jan 27, 2022
Lung Cancer Trial in United States (cytology specimen collection procedure, immunoenzyme technique, study of high risk factors)
Completed
- Lung Cancer
- cytology specimen collection procedure
- +2 more
-
Tampa, Florida
- +4 more
Jun 8, 2022
Lung Cancer Trial in Copenhagen (visicoil gold marker 0.7 x 20 mm)
Completed
- Lung Cancer
- visicoil gold marker 0.7 x 20 mm
-
Copenhagen, DenmarkDepartment of Radiation Oncology, Rigshospitalet
Feb 23, 2021
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in Palo Alto (biological, other, radiation)
Completed
- Stage IA Non-Small Cell Lung Carcinoma
- Stage IB Non-Small Cell Lung Carcinoma
- Fresolimumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Feb 2, 2022
Non-small-cell Lung Cancer Trial (Functional Imaging of Treatment Effects)
Completed
- Non-small-cell Lung Cancer
- Functional Imaging of Treatment Effects
- (no location specified)
Jan 28, 2022
Lung Cancer Trial in Amsterdam (stereotactic radiotherapy, primary surgery)
Terminated
- Lung Cancer
- stereotactic radiotherapy
- primary surgery
-
Amsterdam, NetherlandsVU University Medical Center
Mar 16, 2022
Early-detection Based on Liquid Biopsy in Lung Cancer
Recruiting
- Lung Cancer
-
Beijing, Beijing, ChinaPeking University People's Hospital
Mar 24, 2021
NSCLC Stage I Trial in São Paulo (nivolumab)
Recruiting
- Non-small Cell Lung Cancer Stage I
- nivolumab
-
São Paulo, BrazilHospital Israelita Albert Einstein
Sep 30, 2021
NSCLC Trial in Porto (Durvalumab, standard of care RT/RCT)
Recruiting
- Non-small Cell Lung Cancer
- Durvalumab
- standard of care RT/RCT
-
Porto, PortugalInstituto Português de Oncologia do Porto FG, EPE (IPO-Porto)
Feb 23, 2022
NSCLC Trial in Burlington (cis-diamminedichloroplatinum)
Recruiting
- Non-Small Cell Lung Cancer
-
Burlington, VermontUniversity of Vermont
May 20, 2022
Lung Cancer Stage I, Lung Cancer Stage II, Lung Metastases Trial in Amsterdam, Leiden (Cardiac condition measurements)
Recruiting
- Lung Cancer Stage I
- +2 more
- Cardiac condition measurements
-
Amsterdam, Netherlands
- +2 more
Jul 9, 2021
Lung Tumors, Surgery Trial in Nanjing (Segmentectomy, Lobectomy)
Recruiting
- Lung Neoplasms
- Surgery
- Segmentectomy
- Lobectomy
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital, The First Affiliated Hospital of Nanj
Apr 2, 2022
NSCLC Trial in Kansas City (Non-ablative SBRT)
Recruiting
- Non-small Cell Lung Cancer
- Non-ablative SBRT
-
Kansas City, KansasUniversity of Kansas Medical Center
Mar 21, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +9 more
- Cisplatin
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 17, 2022
Stage II-III NSCLC Trial in Shanghai (4cycles(Toripalimab IV 240mg + platinum-based doublet chemo)+13 cycles(Toripalimab IV
Recruiting
- Stage II-III Non-small Cell Lung Cancer
- 4cycles(Toripalimab IV 240mg + platinum-based doublet chemotherapy)+13 cycles(Toripalimab IV 240mg); Biological: Toripalimab
- 4cycles(Placebo + platinum-based doublet chemotherapy)+13 cycles(Placebo )
-
Shanghai, ChinaShanghai Chest Hospital
Apr 12, 2022